MedPath

Measuring of Neuro-visual Functionality With Ocusweep

Not Applicable
Conditions
Visual Impairment
Interventions
Device: Ocusweep
Device: Ocusweep OcuRT
Registration Number
NCT02258113
Lead Sponsor
Ocuspecto Oy
Brief Summary

The aim of this study is to measure visual acuity, contrast sensitivity and visual field by SAP-method using a novel device Ocusweep compared to currently widely used methods. Addition to that, the aim is to validate a novel perimetry method (Visual Search Test, VST) which is based on reaction times in visual decision- making task, where the subject is allowed to move eyes and where the fixation is verified by the subject himself in contrast to standard automatic perimetry (SAP) where prolonged stationary fixation and external fixation monitoring apparatus is required. Reaction-time based visual field device Ocusweep is compared to generally used SAP methods. Those tests will be done for healthy volunteers and for persons with diagnosed eye or brain disease.

Ocusweep OcuRT vision based choice reaction time test is validated for test repeatability and compared to Trail Making Test (TMT), Useful Field of View (UFOV) and Vienna Test System (VTS) reaction time tests. To evaluate the ability to detect unreliable results, OcuRT test is also done under cognitive load and with instructions to cheat the test.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Healthy volunteers
  • Persons suffering diagnosed eye disease
  • Persons suffering diagnosed brain disease
Exclusion Criteria
  • No diabetes
  • Only one diagnosed disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
LEA numbers, Pelli-Robson, OctopusOcusweepComparable generally used method for measuring visual acuity, contrast sensitivity and visual field.
LEA numbers, Pelli-Robson, OctopusOcusweep OcuRTComparable generally used method for measuring visual acuity, contrast sensitivity and visual field.
Primary Outcome Measures
NameTimeMethod
Visual acuityOne visit per one patient (1h/visit)

Visual acuity is measured as logMAR unit at the one visit for each patient using a novel reaction-time based visual field device and comparable method.

Secondary Outcome Measures
NameTimeMethod
Contrast sensitivityOne visit per one patient (1h/visit)

Contrast sensitivity is measured as logCS unit at the one visit for each patient using a novel reaction-time based visual field device and comparable method.

Reaction time visual fieldOne visit per one patient (1h/visit)

Reaction time is measured using a novel reaction-time based visual field device and compared with generally used visual field program.

Vision based choice reaction timeOne visit per one test subject (1h/visit)

Reaction time is measured with Ocusweep OcuRT test three times to asses repeatability of the test. OcuRT reaction time results will be compared to Trail Making Test (TMT), Useful Field of View (UFOV) and Vienna Test System (VTS) reaction time tests. To evaluate the ability to detect unreliable results, OcuRT will also be done under cognitive load and with instructions to cheat the test.

Trial Locations

Locations (1)

Ocuspecto Oy

🇫🇮

Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath